VALEGRAPH
Enterprise B2B Population Screening

Preventative Screening

Deploy advanced biophysical screening across your healthcare system, reducing diagnostic bottlenecks while improving outcomes and controlling costs.

Healthcare Systems Face a Preventative Care Paradox

Traditional diagnostics are concentrated, capital-intensive, and labour-restricted, preventing early intervention.

Diagnostic Bottleneck

Advanced diagnostic screening technologies remain concentrated in major metropolitan centres, causing rural and regional populations to lack primary access.

80%

Of developing regions lack local diagnostic capacity

Economic Inefficiency

Advanced imaging systems (MRI, CT, Ultrasound) are highly capital-intensive, leading to constrained budgets that prevent population-wide preventative deployment.

$1.5K+

Average institutional cost per advanced scan

Workforce Strain

A severe global shortage of specialised diagnostic radiologists and medical specialists creates diagnostic workflow bottlenecks, delaying patient treatments.

60%

Of countries experience clinical operator deficits

The VALEOGRAPH Institutional Solution

Our technology transforms preventative care economics by democratising clinical diagnostic infrastructure at scale.

Democratised Access

Deploy screening stations in diverse settings—urban hospitals, rural health posts, and mobile clinics. Minimal local infrastructure required.

Learn about deployment models

Economic Viability

Significantly lower cost-per-screening compared to ultrasound and MRI modalities, allowing population-scale budgeting within state resources.

Understand the economic models

Operational Scalability

Rapid clinical integration without workflow disruption. Staff operators onboard in days, not months. High-throughput diagnostics.

Review implementation approaches

EHR Data Interoperability

Seamless automated data synchronisation with national health databases, EHR networks, and managed care analytical stratification consoles.

Explore data security architectures
VALEOGRAPH Prevent Professional 980 Diagnostic Console
Hardware Modality Station

VALEOGRAPH Prevent Professional 980

The official enterprise-grade diagnostic station combines HRV, ECG, Diagonal-Segmental Amplitudometry (DSAM), Vegetative Organ Diagnostics (VALEO), and Bio-Impedance Analysis (BIA) in a single integrated physical screening console.

Non-Invasive Systems Scan in under 10 minutes High-Throughput B2B Preventative Triage

Tailored Solutions for Healthcare Slices

Jump directly into specialised programmes designed to meet the exact evaluation requirements of your medical sector.

Government & Public Health

Deploy national-scale screening programmes to improve regional health metrics, data sovereignty, and preventative budgets.

Explore Sector

Hospital Networks

Improve patient throughput, establish rapid functional diagnostics, and integrate screening seamlessly with clinical legacy EHR.

Explore Sector

Private Institutions

Maximize outpatient margins via premium cash-pay diagnostics and state-of-the-art diagnostic screening differentials.

Explore Sector

Insurance & Payors

Address population risk adjustment and early intervention metrics while decreasing managed care claims over time.

Explore Sector

Corporate Wellness

Boost employee productivity and satisfaction indices with on-site preventative diagnostics and corporate care packages.

Explore Sector

NGOs & Development

Deploy rugged, portable diagnostic units in resource-restricted populations to bypass traditional brick-and-mortar clinics.

Explore Sector

Trusted by Healthcare Systems Worldwide

Demonstrated operational stability and clinical adoption across international regions.

0
Institutions
0
Screenings
0
Countries

VALEOGRAPH's robust clinical and administrative network extends across key healthcare infrastructures, facilitating prevention economics at national ministries and premium private clinics.

Explore for Your Sector

VALEOGRAPH Global Office Centres

Establish direct acquisition and support linkages with our global offices.

Headquarters

VALEOGRAPH Deutschland GmbH
Friedenstraße 36, 33602 Bielefeld, Germany

Founder & CEO: Ali Diboglu
Medical Director: Dr. Alexej Bedasch
Phone: +49 5221 764533 | Fax: +49 5221 764532

info@valeograph.de

UK Contact Point

VALEOGRAPH UK Correspondence
5 Brayford Square, London, England, E1 0SG

Contact use: Regional correspondence and partner enquiries

enquiries@valeograph.co
VALEOGRAPH headquarters building

VALEOGRAPH Headquarters

Our headquarters in Bielefeld, Germany supports product development, partner coordination, and clinical technology operations for VALEOGRAPH deployments.

ISO 27001 & CE MDR Certified Facility

Proven Regulatory Compliance & Clinical Validation

VALEOGRAPH meets rigorous healthcare standardisations and privacy mandates globally.

CE Mark Class IIa

MDR EU 2017/745 Compliant

GDPR Compliant

Data Sovereignty Ensured

HIPAA Capable

PHR Security Standards

ISO 27001

Information Security Certified

Begin Your Institutional Evaluation

We coordinate structured evaluation pathways tailored to your current procurement and budget cycle.

1. Exploration

Understand how VALEOGRAPH maps onto your sector. Review localised whitepapers, economic models, and resource plans.

Explore Sektor Portals

2. Assessment & Demo

Request an interactive system demonstration with a clinical advisor. Review diagnostic console and operator dashboards.

3. Decision & RFP

Access formal RFP templates, feasibility questionnaires, scale rollout schedules, and procurement legal files.

VALEOGRAPH for Government & Public Health

Extend affordable preventative diagnostic screenings to entire regions, closing geographic health disparities within constrained budgets.

VALEOGRAPH Clinical Ecosystem Infographic from PDF Documentation
1

Geographic Isolation

Rural communities lack complex diagnostic imaging access, delaying critical clinical assessments until patients show severe symptoms.

2

Escalating Healthcare Costs

Late-stage acute treatments inflate public health budgets. Preventative screening remains operationally too expensive to scale.

Solution Benefits Mapping

VALEOGRAPH provides a direct solution map matching key health ministry challenges:

Democratised Rural Access: Light, portable diagnostic nodes operate in standard clinics without radiological shielding.
Drastically Lower Cost-per-Scan: Reduces diagnostic costs by up to 60%, unlocking national screening budgets.
Predictive Public Analytics: Direct national database telemetry tracks population risks, enabling proactive health budgeting.

State Rollout Implementation Roadmap

01
Alignment
Weeks 1 - 4
02
Pilot
Weeks 5 - 12
03
Rollout
Months 4 - 12
04
Scale
Year 2+
Government Health Ministry CE MDR Certified

National Preventative Care Initiative

The Ministry of Health of an EU member state deployed 50 VALEOGRAPH stations across rural and metropolitan community clinics. The target was to bypass traditional specialist waiting loops, establishing early preventative health indices on functional biological systems.

"The operational deployment of VALEOGRAPH stations has fundamentally altered our prevention economics. We have successfully closed regional diagnostic gaps while detecting system variations before expensive hospitalisation loops are entered."
— Director of Public Health Integration

Quantified Pilot Outcomes

500K
Citizens Screened
-45%
Cost-per-Screening
23%
Early Efficacy Detection
-18%
Preventable Admissions

Government-Specific Questions

How does VALEOGRAPH integrate with national electronic medical records (EHR)?
The platform features built-in HL7/FHIR compliance, enabling secure API synchronisation with state health registries. Screenings export automated structured clinical data packages to existing medical databases instantly.
What data sovereignty and local server configurations are supported?
To satisfy regional regulatory mandates, VALEOGRAPH can be deployed in secure local clouds or hosted entirely on state-owned physical servers behind government firewalls, guaranteeing total data sovereignty.

Regulatory Framework & Data Compliance Centre

Unwavering compliance with global health standards, device regulations, and regional data protection protocols.

CE Medical Device Class IIa

EU MDR 2017/745

VALEOGRAPH satisfies all medical device safety and diagnostic efficacy standards for public population deployment. Full declaration of conformity documents and clinical safety reviews are accessible.

GDPR Compliant Architecture

Data Sovereignty Standards

Features standard patient end-to-end data encryption and anonymised clinical storage. Integrates smoothly with native cloud storage configurations inside national borders.

Controlled Compliance Documents

Technical and regulatory documents are shared directly with qualified institutional partners during due diligence.